These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15476285

  • 1. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
    Grassmann S, Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Arch Pharm (Weinheim); 2004 Oct; 337(10):533-45. PubMed ID: 15476285
    [Abstract] [Full Text] [Related]

  • 2. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Schwartz JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8729-36. PubMed ID: 18774720
    [Abstract] [Full Text] [Related]

  • 3. Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.
    Grassmann S, Apelt J, Sippl W, Ligneau X, Pertz HH, Zhao YH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2003 May 15; 11(10):2163-74. PubMed ID: 12713826
    [Abstract] [Full Text] [Related]

  • 4. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
    Łazewska D, Kuder K, Ligneau X, Camelin JC, Schunack W, Stark H, Kieć-Kononowicz K.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3037-42. PubMed ID: 19329325
    [Abstract] [Full Text] [Related]

  • 5. Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.
    Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2002 Feb 28; 45(5):1128-41. PubMed ID: 11855993
    [Abstract] [Full Text] [Related]

  • 6. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253
    [Abstract] [Full Text] [Related]

  • 7. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Bioorg Med Chem; 2004 May 15; 12(10):2727-36. PubMed ID: 15110854
    [Abstract] [Full Text] [Related]

  • 8. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.
    Apelt J, Grassmann S, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    Pharmazie; 2005 Feb 15; 60(2):97-106. PubMed ID: 15739896
    [Abstract] [Full Text] [Related]

  • 9. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1151-9. PubMed ID: 10215699
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.
    Ishikawa M, Furuuchi T, Yamauchi M, Yokoyama F, Kakui N, Sato Y.
    Bioorg Med Chem; 2010 Jul 15; 18(14):5441-8. PubMed ID: 20541426
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M, Watanabe T, Kudo T, Yokoyama F, Yamauchi M, Kato K, Kakui N, Sato Y.
    J Med Chem; 2010 Sep 09; 53(17):6445-56. PubMed ID: 20690643
    [Abstract] [Full Text] [Related]

  • 12. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.
    Petroianu G, Arafat K, Sasse BC, Stark H.
    Pharmazie; 2006 Mar 09; 61(3):179-82. PubMed ID: 16599255
    [Abstract] [Full Text] [Related]

  • 13. A new family of H3 receptor antagonists based on the natural product Conessine.
    Santora VJ, Covel JA, Hayashi R, Hofilena BJ, Ibarra JB, Pulley MD, Weinhouse MI, Sengupta D, Duffield JJ, Semple G, Webb RR, Sage C, Ren A, Pereira G, Knudsen J, Edwards JE, Suarez M, Frazer J, Thomsen W, Hauser E, Whelan K, Grottick AJ.
    Bioorg Med Chem Lett; 2008 Feb 15; 18(4):1490-4. PubMed ID: 18194865
    [Abstract] [Full Text] [Related]

  • 14. A chemical switch for the modulation of the functional activity of higher homologues of histamine on the human histamine H3 receptor: effect of various substitutions at the primary amino function.
    Govoni M, Lim HD, El-Atmioui D, Menge WM, Timmerman H, Bakker RA, Leurs R, De Esch IJ.
    J Med Chem; 2006 Apr 20; 49(8):2549-57. PubMed ID: 16610798
    [Abstract] [Full Text] [Related]

  • 15. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
    Incerti M, Flammini L, Saccani F, Morini G, Comini M, Coruzzi M, Barocelli E, Ballabeni V, Bertoni S.
    ChemMedChem; 2010 Jul 05; 5(7):1143-9. PubMed ID: 20512794
    [Abstract] [Full Text] [Related]

  • 16. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T, Sander K, Weizel L, Schneider EH, Seifert R, Stark H.
    Eur J Pharmacol; 2011 Mar 11; 654(3):200-8. PubMed ID: 21237145
    [Abstract] [Full Text] [Related]

  • 17. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang JM.
    Br J Pharmacol; 2006 Apr 11; 147(7):744-54. PubMed ID: 16432504
    [Abstract] [Full Text] [Related]

  • 18. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I, Figlus M, Zuiderveld OP, Walczynski K.
    Arch Pharm (Weinheim); 2008 Dec 11; 341(12):762-73. PubMed ID: 19009544
    [Abstract] [Full Text] [Related]

  • 19. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
    Sasse BC, Mach UR, Leppaenen J, Calmels T, Stark H.
    Bioorg Med Chem; 2007 Dec 01; 15(23):7258-73. PubMed ID: 17826096
    [Abstract] [Full Text] [Related]

  • 20. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2004 May 06; 47(10):2678-87. PubMed ID: 15115409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.